You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Novel Recombinant Protein for Mitigating Total Body Radiation Injury
SBC: THERASOURCE, LLC Topic: NIAIDDESCRIPTION provided by applicant This SBIR Phase I proposal is intended to demonstrate the feasibility of developing a novel and effective therapeutic agent for acute radiation injury The threat of nuclear terrorism remains high and there is a possibility of a nuclear power plant leak both of which can cause acute radiation injury at a large scale Currently there are no therapeutic agents ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Real-time Alpha-Flow Traffic Management System
SBC: Reservoir Labs, Inc. Topic: 01aAs supercomputing speeds increase and storage costs drop, scientists running applications in various disci- plines, such as high-energy physics, genomics, climate studies, etc., generate datasets of ever-increasing sizes at distributed locations around the world. Backbone Research-and-Education Network (REN) providers such as DOEs Energy Sciences Network (ESnet) and Internet2, provide high-speed, ...
SBIR Phase I 2014 Department of Energy -
Science Take-Out Kits for Environmental Health Education
SBC: Science Take-Out, LLC Topic: NIEHSDESCRIPTION provided by applicant Nearly percent of death and disease worldwide is linked to environmental factors WHO therefore it is critical that the general public has basic understanding of how the environment affects their health and how they might protect themselves against environmental exposures Unfortunately environmental health content is typically covered on a very ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development and in vitro validation of therapy for mucopolysaccharidosis III
SBC: Phoenix Nest Inc. Topic: 105DESCRIPTION provided by applicant Sanfilippo disease mucopolysaccharidosis type III MPS III is a devastating neurodegenerative lysosomal storage disorder of childhood for which there is no cure or effective treatment available The fundamental cause of MPS III is an inherited mutation in one of the enzymes required to catabolize heparan sulfate HS a glycosaminoglycan which plays importa ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Enhancing engraftment of cord blood for treatment of neoplastic disorders
SBC: Marrowsource Therapeutics International LLC Topic: NHLBIDESCRIPTION provided by applicant Hematopoietic stem cell transplantation is a form of stem cell therapy used to treat cancers such as lymphoma and leukemia and other blood related diseases However there currently are several drawbacks in the use of bone marrow hematopoietic cell transplantation Most importantly the donor pool is limited by the need for at least partial HLA matching and t ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Cell therapy for Repairing Warm Ischemically Damaged Kidneys
SBC: BREONICS, INC. Topic: NIAIDDESCRIPTION provided by applicant The goal of this project is address a large unmet medical need by providing more kidneys for transplant For the andgt patients with end stage renal disease in the U S the pool of cadaveric kidneys has remained stagnant over the past decade As a result the dialysis population is expected to reach andgt million patients in the next decade at an aggr ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Preclinical Testing of Human Ghrelin for the Treatment of Stroke
SBC: THERASOURCE, LLC Topic: 105DESCRIPTION provided by applicant The ultimate objective of this program is to develop a novel therapeutic approach that will save lives of patients with stroke Acute stroke is the third leading cause of death in the United States and the primary medical cause of acquired adult disability Each year Americans experience new or recurrent stroke It accounts for out of every death ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Dityrosine Locked Prefusion F Protein: A Path To A Protective RSV Vaccine
SBC: AVATAR MEDICAL, LLC Topic: NIAIDDESCRIPTION provided by applicant The pre fusion conformation of the RSV F protein preF is the primary determinant of neutralization in immunized sera However this conformation is unstable and rapidly transitions to the postfusion conformation A disulfide stabilized prefusion variant with cavity filling mutations DS Cav has been shown to yield high neutralizing titers in animals howeve ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Ultra-low dose Influenza vaccines
SBC: Codagenix Inc. Topic: NIAIDDESCRIPTION provided by applicant Current seasonal Influenza vaccines are proving to be ineffective especially in at risk populations For example this yearandapos s inactivated flu vaccine had only a efficacy rate against H N infections in the elderly and the current live attenuated Influenza vaccine LAIV is aged restricted for those above years of age Therefore there is glaring un ...
SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of an Antigen Capture Assay for Babesia microti
SBC: BIOPEPTIDES CORP Topic: NIAIDDESCRIPTION provided by applicant Babesia microti the primary etiologic agent of human babesiosis is a tick borne eukaryotic apicomplexan pathogen that is an increasing threat to the US public health Although B microti is primarily a tick borne pathogen it can be transmitted by transfusion of infected blood Despite the well recognized threat there is no FDA licensed test to screen donor ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health